Liposomal Antitumor Vaccines Targeting Mucin 1 Elicit a Lipid‐Dependent Immunodominant Response-Reference-Cited by-同舟云学术

Liposomal Antitumor Vaccines Targeting Mucin 1 Elicit a Lipid‐Dependent Immunodominant Response

Published:2019-05-21 Issue:12 Volume:14 Page:2116-2121
ISSN:1861-4728
Container-title:Chemistry – An Asian Journal
language:en
Short-container-title:Chem. Asian J.

Author:

Du Jing‐Jing¹,Zou Shi‐Yao¹,Chen Xiang‐Zhao¹,Xu Wen‐Bo¹,Wang Chang‐Wei¹,Zhang Lian¹,Tang Yuan‐Kai¹,Zhou Shi‐Hao¹,Wang Jian¹,Yin Xu‐Guang¹,Gao Xiao‐Fei²,Liu Zheng¹^ORCID,Guo Jun¹^ORCID

Affiliation:

1. Key Laboratory of Pesticide & Chemical Biology of Ministry of EducationHubei International Scientific and Technological Cooperation Base of Pesticide and Green SynthesisInternational Joint Research Center for Intelligent Biosensing Technology and HealthCollege of ChemistryCentral China Normal University Wuhan Hubei 430079 China

2. Jiangxi Key Laboratory for Mass Spectrometry and InstrumentationEast China University of Technology Nanchang Jiangxi 330013 China

Publisher

Wiley

Subject

General Chemistry,Biochemistry,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/asia.201900448

Reference73 articles.

1. Role of E Box and Initiator Region in the Expression of the Rat Follicle-stimulating Hormone Receptor

2. T and Tn, General Carcinoma Autoantigens

4. MUC1 as a target antigen for cancer immunotherapy

5. MUC1: A target molecule for cancer therapy

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic self‐adjuvanted multivalent Mucin 1 (MUC1) glycopeptide vaccines with improved in vivo antitumor efficacy;MedComm;2024-02

2. Trichostatin A-modified vaccine provides superior protection against ovarian cancer formation and development;Brazilian Journal of Medical and Biological Research;2024

3. Subunit protein-based vaccines;Advanced Vaccination Technologies for Infectious and Chronic Diseases;2024

4. Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidate;Journal of the American Chemical Society;2023-06-21

5. Self-Adjuvanting Protein Vaccine Conjugated with a Novel Synthetic TLR4 Agonist on Virus-Like Liposome Induces Potent Immunity against SARS-CoV-2;Journal of Medicinal Chemistry;2023-01-10